SlideShare a Scribd company logo
Differences in side-effect assessment between healthcare professionals and patients Lesley Fallowfield Brighton & Sussex Medical School
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]
Patients and clinicians may have different values ,[object Object],[object Object],[object Object],[object Object]
Decisions patients face ,[object Object],[object Object],[object Object],[object Object]
Do we have the data patients need for optimal decision-making ? ,[object Object],[object Object],[object Object],[object Object]
Common Terminology Criteria for Adverse Events (CTCAE) ,[object Object],[object Object],[object Object],[object Object],[object Object]
PROs v. physician reports using CTC for AE   (Basch et al, Lancet Onc, 2006) ,[object Object],[object Object],[object Object],[object Object]
Concordance - clinician recorded v PROs ,[object Object],[object Object],[object Object],[object Object]
Benefit/harms of hormone therapy ,[object Object],[object Object],[object Object],[object Object],[object Object]
Concordance of Symptom Reports of Any Severity  (Coombes, 2003) Symptoms % Prevalence CRF  PRO Kappa 95% CI Hot flushes 49.8  73.5 0.73 ** .70 - .75 Fatigue 21.0  71.5 0.72 ** .41 - .47 Insomnia 17.9  69.4 0.45 * .42 - .48 Headaches 15.8  48.7 0.66 ** .63 - .69 Dizziness 9.5  32.1 0.72 ** .69 - .75 Vaginal bleeding 2.7  5.4 0.97 *** .96 - .98
What are the primary goals of MBC treatment ? ,[object Object],[object Object],[object Object],[object Object]
Nurses’ assessments of advanced cancer patients  (Stromgren et al, 2001) ,[object Object],[object Object],[object Object],[object Object],Item NSR (%) pain 84 physical function 84 nausea 64 vomiting 58 anorexia 41 dyspnoea 46 fatigue 36 sleeplessness 0 poor QoL 0
Why are there differences ? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgements ,[object Object]

More Related Content

What's hot

Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...
Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...
Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...
Informed Medical Decisions Foundation
 
Making a New Cancer Treatment Decision
Making a New Cancer Treatment DecisionMaking a New Cancer Treatment Decision
Making a New Cancer Treatment Decision
Shannon Watterson
 
Baseline Medication use in ADNI
Baseline Medication use in ADNIBaseline Medication use in ADNI
Baseline Medication use in ADNI
nue2you
 
Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!
RxVichuZ
 
Erectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis Patients
Erectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis PatientsErectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis Patients
Erectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis Patients
asclepiuspdfs
 
Geriatric oncology 2019
Geriatric oncology 2019Geriatric oncology 2019
Geriatric oncology 2019
Marc Evans Abat
 
012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults
Georgi Daskalov
 
Immunotherapy - the promises and pitfalls
Immunotherapy - the promises and pitfallsImmunotherapy - the promises and pitfalls
Immunotherapy - the promises and pitfalls
SCGH ED CME
 
Race and Variations in Operative Treatment 10.22.09
Race and Variations in Operative Treatment 10.22.09Race and Variations in Operative Treatment 10.22.09
Race and Variations in Operative Treatment 10.22.09
Leonard Davis Institute of Health Economics
 
Journal club vitamin c
Journal club vitamin c Journal club vitamin c
Journal club vitamin c Yassin Alsaleh
 
Switching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosisSwitching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosis
Divya Shilpa
 
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Farooq Khan
 
The role of primary care in the management of crf patients
The role of primary care in the management of crf patientsThe role of primary care in the management of crf patients
The role of primary care in the management of crf patients
Ivan De Paz Mejia
 
Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...
Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...
Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...
University of Michigan Department of Emergency Medicine
 
Final Journal Club Presentation
Final Journal Club PresentationFinal Journal Club Presentation
Final Journal Club PresentationAnna Schemel
 
Giải pháp cho người bị hói
Giải pháp cho người bị hóiGiải pháp cho người bị hói
Giải pháp cho người bị hói
hieusach-kimnhung
 
Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7
Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7
Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7
Leonard Davis Institute of Health Economics
 
Understanding clinical trials
Understanding clinical trialsUnderstanding clinical trials
Understanding clinical trials
MS Trust
 

What's hot (20)

Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...
Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...
Decisions about Medication Use and Cancer Screening Among Elderly Adults in t...
 
Making a New Cancer Treatment Decision
Making a New Cancer Treatment DecisionMaking a New Cancer Treatment Decision
Making a New Cancer Treatment Decision
 
Baseline Medication use in ADNI
Baseline Medication use in ADNIBaseline Medication use in ADNI
Baseline Medication use in ADNI
 
Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!
 
Erectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis Patients
Erectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis PatientsErectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis Patients
Erectile Dysfunction and Risk Factors in Male Peruvian Hemodialysis Patients
 
Geriatric oncology 2019
Geriatric oncology 2019Geriatric oncology 2019
Geriatric oncology 2019
 
012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults
 
Immunotherapy - the promises and pitfalls
Immunotherapy - the promises and pitfallsImmunotherapy - the promises and pitfalls
Immunotherapy - the promises and pitfalls
 
Race and Variations in Operative Treatment 10.22.09
Race and Variations in Operative Treatment 10.22.09Race and Variations in Operative Treatment 10.22.09
Race and Variations in Operative Treatment 10.22.09
 
Journal club vitamin c
Journal club vitamin c Journal club vitamin c
Journal club vitamin c
 
Switching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosisSwitching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosis
 
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
 
The role of primary care in the management of crf patients
The role of primary care in the management of crf patientsThe role of primary care in the management of crf patients
The role of primary care in the management of crf patients
 
Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...
Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...
Blood Product Transfusion in Emergency Departments: a Case-Control Study of P...
 
Final Journal Club Presentation
Final Journal Club PresentationFinal Journal Club Presentation
Final Journal Club Presentation
 
Giải pháp cho người bị hói
Giải pháp cho người bị hóiGiải pháp cho người bị hói
Giải pháp cho người bị hói
 
HO-JC.NOWICKI- Azith v. Doxy in C.Trach Inf
HO-JC.NOWICKI- Azith v. Doxy in C.Trach InfHO-JC.NOWICKI- Azith v. Doxy in C.Trach Inf
HO-JC.NOWICKI- Azith v. Doxy in C.Trach Inf
 
Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7
Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7
Impact of Acgme Duty Hour Rules on Prolonged Length of Stay Among Medicare 4.7
 
ISPOR podium presentation
ISPOR podium presentationISPOR podium presentation
ISPOR podium presentation
 
Understanding clinical trials
Understanding clinical trialsUnderstanding clinical trials
Understanding clinical trials
 

Similar to ABC1 - L. Fallowfield - Differencies in side effects assessment among doctors, nurses and patients

Nejm journal watch practice changing articles 2014
Nejm journal watch   practice changing articles 2014Nejm journal watch   practice changing articles 2014
Nejm journal watch practice changing articles 2014Jaime dehais
 
Clinical Research Methodology
Clinical  Research  MethodologyClinical  Research  Methodology
Clinical Research Methodologydrmomusa
 
MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...
MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...
MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...European School of Oncology
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015
Colin McCartney
 
BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer
BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer
BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer European School of Oncology
 
Systematic reviews of adverse effects and other topics not – yet – covered by...
Systematic reviews of adverse effects and other topics not – yet – covered by...Systematic reviews of adverse effects and other topics not – yet – covered by...
Systematic reviews of adverse effects and other topics not – yet – covered by...
Cochrane.Collaboration
 
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipMON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipEuropean School of Oncology
 
Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017
Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017
Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017
Colin McCartney
 
Randomised Controlled Trials
Randomised Controlled TrialsRandomised Controlled Trials
Randomised Controlled Trialsfondas vakalis
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015
Colin McCartney
 
Evidence to Decision tables – 11th CE&B's research day presentation
Evidence to Decision tables – 11th CE&B's research day presentationEvidence to Decision tables – 11th CE&B's research day presentation
Evidence to Decision tables – 11th CE&B's research day presentation
Carlos Cuello
 
Balancing Risks and Benefits of Regional Anaesthesia
Balancing Risks and Benefits of Regional AnaesthesiaBalancing Risks and Benefits of Regional Anaesthesia
Balancing Risks and Benefits of Regional Anaesthesia
Colin McCartney
 
U_of_Kansas_ACOVE_PerioperativeCareGeriatrics.ppt
U_of_Kansas_ACOVE_PerioperativeCareGeriatrics.pptU_of_Kansas_ACOVE_PerioperativeCareGeriatrics.ppt
U_of_Kansas_ACOVE_PerioperativeCareGeriatrics.ppt
rasulataswain1
 
How to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancyHow to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancy
Rajesh Gajbhiye
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simba Takuva
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
inemet
 
Referral For Invasive Procedures For Cancer Pain Dr Alison Mitchell
Referral For Invasive Procedures For Cancer Pain   Dr Alison MitchellReferral For Invasive Procedures For Cancer Pain   Dr Alison Mitchell
Referral For Invasive Procedures For Cancer Pain Dr Alison Mitchell
epicyclops
 
Age Bias in Cancer Care
Age Bias in Cancer CareAge Bias in Cancer Care
Age Bias in Cancer Care
bkling
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation
Group Health Cooperative
 

Similar to ABC1 - L. Fallowfield - Differencies in side effects assessment among doctors, nurses and patients (20)

Nejm journal watch practice changing articles 2014
Nejm journal watch   practice changing articles 2014Nejm journal watch   practice changing articles 2014
Nejm journal watch practice changing articles 2014
 
Clinical Research Methodology
Clinical  Research  MethodologyClinical  Research  Methodology
Clinical Research Methodology
 
MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...
MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...
MON 2011 - Slide 28 - S. Faithfull - Spotlight session - Consequences of canc...
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015
 
BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer
BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer
BALKAN MCO 2011 - R. Curca - Palliative and supportive care in lung cancer
 
Systematic reviews of adverse effects and other topics not – yet – covered by...
Systematic reviews of adverse effects and other topics not – yet – covered by...Systematic reviews of adverse effects and other topics not – yet – covered by...
Systematic reviews of adverse effects and other topics not – yet – covered by...
 
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipMON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
 
Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017
Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017
Whistler Anesthesia Symposium Regional Anesthesia Outcomes 2017
 
Randomised Controlled Trials
Randomised Controlled TrialsRandomised Controlled Trials
Randomised Controlled Trials
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015
 
Evidence to Decision tables – 11th CE&B's research day presentation
Evidence to Decision tables – 11th CE&B's research day presentationEvidence to Decision tables – 11th CE&B's research day presentation
Evidence to Decision tables – 11th CE&B's research day presentation
 
Balancing Risks and Benefits of Regional Anaesthesia
Balancing Risks and Benefits of Regional AnaesthesiaBalancing Risks and Benefits of Regional Anaesthesia
Balancing Risks and Benefits of Regional Anaesthesia
 
MCC 2011 - Slide 22
MCC 2011 - Slide 22MCC 2011 - Slide 22
MCC 2011 - Slide 22
 
U_of_Kansas_ACOVE_PerioperativeCareGeriatrics.ppt
U_of_Kansas_ACOVE_PerioperativeCareGeriatrics.pptU_of_Kansas_ACOVE_PerioperativeCareGeriatrics.ppt
U_of_Kansas_ACOVE_PerioperativeCareGeriatrics.ppt
 
How to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancyHow to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancy
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
 
Referral For Invasive Procedures For Cancer Pain Dr Alison Mitchell
Referral For Invasive Procedures For Cancer Pain   Dr Alison MitchellReferral For Invasive Procedures For Cancer Pain   Dr Alison Mitchell
Referral For Invasive Procedures For Cancer Pain Dr Alison Mitchell
 
Age Bias in Cancer Care
Age Bias in Cancer CareAge Bias in Cancer Care
Age Bias in Cancer Care
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation
 

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 

Recently uploaded

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 

Recently uploaded (20)

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 

ABC1 - L. Fallowfield - Differencies in side effects assessment among doctors, nurses and patients

  • 1. Differences in side-effect assessment between healthcare professionals and patients Lesley Fallowfield Brighton & Sussex Medical School
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. Concordance of Symptom Reports of Any Severity (Coombes, 2003) Symptoms % Prevalence CRF PRO Kappa 95% CI Hot flushes 49.8 73.5 0.73 ** .70 - .75 Fatigue 21.0 71.5 0.72 ** .41 - .47 Insomnia 17.9 69.4 0.45 * .42 - .48 Headaches 15.8 48.7 0.66 ** .63 - .69 Dizziness 9.5 32.1 0.72 ** .69 - .75 Vaginal bleeding 2.7 5.4 0.97 *** .96 - .98
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.